Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
International Journal of Molecular Sciences|August 12, 2022
FOXM1 Is a Novel Molecular Target of AFP-Positive Hepatocellular Carcinoma Abrogated by Proteasome InhibitionRu Li, Hikari Okada, Taro Yamashita, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 21, 2020
Comparative analysis of liver functional reserve during lenvatinib and sorafenib for advanced hepatocellular carcinomaTakeshi Terashima, Tatsuya Yamashita, Noboru Takata, et al.
Clinical Endoscopy|April 12, 2023
Necessity of pharyngeal anesthesia during transoral gastrointestinal endoscopy: a randomized clinical trialTomoyuki Hayashi, Yoshiro Asahina, Yasuhito Takeda, et al.
Journal of Gastroenterology and Hepatology|March 18, 2020
IL-28B variant as a predictor in patients with advanced hepatocellular carcinoma treated with hepatic arterial infusion chemotherapyTakeshi Terashima, Masao Honda, Tadashi Toyama, et al.
Cancer Cell International|October 28, 2017
Sporadic PCDH18 somatic mutations in EpCAM-positive hepatocellular carcinomaTakehiro Hayashi, Taro Yamashita, Hikari Okada, et al.
International Journal of Molecular Sciences|May 13, 2023
Plasma Antithrombin III Levels Can Be a Prognostic Factor in Liver Cirrhosis Patients with Portal Vein ThrombosisTsuyoshi Suda, Hajime Takatori, Takehiro Hayashi, et al.
Stem Cell Research & Therapy|July 6, 2025
Therapeutic effects of adipose tissue-derived mesenchymal stem cells on ER stress in a murine model of metabolic dysfunction-associated steatohepatitis: an in vivo and in vitro studyNorihiko Ogawa, Akihiro Seki, Alessandro Nasti, et al.
Cancers|January 25, 2025
Phase II Study of Atezolizumab and Bevacizumab Combination Therapy for Patients with Advanced Hepatocellular Carcinoma Previously Treated with LenvatinibTakeshi Terashima, Hidenori Kido, Noboru Takata, et al.
Scientific Reports|September 14, 2017
Sorafenib suppresses extrahepatic metastasis de novo in hepatocellular carcinoma through inhibition of mesenchymal cancer stem cells characterized by the expression of CD90Mariko Yoshida, Taro Yamashita, Hikari Okada, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 3, 2025
The efficacy and safety of adding hepatic arterial infusion chemotherapy using cisplatin to lenvatinib for advanced hepatocellular carcinomaTakeshi Terashima, Makoto Yamamoto, Tadashi Toyama, et al.
Pageof 8